Miromatrix Medical Inc
NASDAQ:MIRO
Miromatrix Medical Inc
Cash from Operating Activities
Miromatrix Medical Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Miromatrix Medical Inc
NASDAQ:MIRO
|
Cash from Operating Activities
-$26.7m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Operating Activities
$8.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
|
Danaher Corp
NYSE:DHR
|
Cash from Operating Activities
$7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Operating Activities
$1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Operating Activities
$2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
See Also
What is Miromatrix Medical Inc's Cash from Operating Activities?
Cash from Operating Activities
-26.7m
USD
Based on the financial report for Dec 31, 2022, Miromatrix Medical Inc's Cash from Operating Activities amounts to -26.7m USD.
What is Miromatrix Medical Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-47%
Over the last year, the Cash from Operating Activities growth was -80%. The average annual Cash from Operating Activities growth rates for Miromatrix Medical Inc have been -47% over the past three years .